AlphaYou
Overview
Key stats
Fundamentals Sep 10- Open
- $80.53
- 52-wk high
- $94.00
- High
- $80.53
- 52-wk low
- $56.94
- Low
- $78.59
- Prev close
- $80.32
- Mkt cap
- $4.15B
- P/E
- 22.5x
- Volume
- 360.0K
- Fwd P/E
- 10.6x
- Beta
- 0.83
- Div yield
- 2.24%
- P/S
- 1.1x
- P/B
- 2.6x
- Profit margin
- +5.2%
- Op margin
- +14.3%
- ROE
- +13.4%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsSmart money
Earnings
Earnings landed in line with what analysts expected.
Earnings per share
$1.66 expected
Reports Nov 2, 2026, in 53 days
EPS expected
$1.43 to $1.54
Revenue expected
5 analysts
Last 30 days
Analysts raising estimates
Estimate drift
Change in 30 days
Financials
What it sold, what it cost, what was left.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $899.0M | $849.0M | $904.0M | $982.0M |
| Cost of what it sold | $679.0M | $638.0M | $687.0M | $798.0M |
| Gross profit | $220.0M | $211.0M | $217.0M | $184.0M |
| What it spent | ||||
| Research and development | $15.0M | $13.0M | $14.0M | $13.0M |
| Sales and admin | $68.0M | $69.0M | $67.0M | $73.0M |
| Other operating costs | — | — | -$1.0M | — |
| Total operating expenses | $83.0M | $82.0M | $80.0M | $86.0M |
| What was left | ||||
| Operating profit | $137.0M | $129.0M | $137.0M | $98.0M |
| Interest on debt | $20.0M | $18.0M | $19.0M | $18.0M |
| Profit before tax | $117.0M | $119.0M | $122.0M | $60.0M |
| Tax | $63.0M | $37.0M | $44.0M | $46.0M |
| Net profit | $43.0M | $73.0M | $68.0M | $6.0M |
| EBITDA | $175.0M | $177.0M | $190.0M | $148.0M |
Technicals
Price structure
This stock is under pressure, and looks oversold after a sharp drop.
Trend
Under pressure
25 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
News
What the news says
Coverage is bullish
Tone of tracked coverage
Cabot (NYSE:CBT): Is the Market Too Cautious Now?
Leans bullishSep 7Cabot Corporation $CBT Position Raised by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Leans bullishSep 7Corient Private Wealth LP Takes Position in Cabot Corporation $CBT
Leans bullishSep 523,283 Shares in Cabot Corporation $CBT Purchased by Jupiter Topco LLC
NeutralSep 4Legal & General Group Plc Purchases New Position in Cabot Corporation $CBT
Leans bullishSep 3The Manufacturers Life Insurance Company Acquires Shares of 47,211 Cabot Corporation $CBT
NeutralSep 1Cabot Corp president and CEO Sean Keohane sells $11.4 million in stock
NeutralSep 1Cabot Corporation CEO Sean D. Keohane Exercises Stock Options and Sells 134,895 Shares on August 28, 2026
NeutralSep 1
Macro
11 macro signals shaping CBT right now
Unlock sector rotation, regime shifts, and macro event windows tied to this stock.
Unlock the full results